Finzati - Logo
LYEL logo

Lyell Immunopharma, Inc.

LYEL • Biotechnology
$14.37
▲ +0.05 (+0.35%)
Current price
EarningsLatest report: Mar 31, 2026
WEAK PROFILEWeakConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$314.36M
Growth
-41.6%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.17Healthy liquidity · 5.28Negative growth trendWeak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 6, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$14.37
Change0.35%
Shares Out21.88M
Market Cap$314.36M
Enterprise Value$99.82M
52W Range9.03 - 45.00
Beta-0.09
P/E-1.28
P/S10,140.58
P/B1.15
P/FCF-2.34
EV/Sales3,220.07

Investment DNA

How strong this company looks for long-term investors

35
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
53/100
Why this score▼
Manageable debt level · 0.17Healthy liquidity · 5.28Negative growth trendWeak profitability

Analyst view

Analyst sentiment and price target

LYEL
Analyst sentiment
Based on 7 analyst votes · 2026-09-05
64/100
Neutral
Bullish
3
Hold
3
Bearish
1
Price Target
2026-07-02
Low
$45.00
Mean
$47.00
Median
$47.00
High
$49.00

Company Overview

IPO: 6/17/2021
Industry: Biotechnology
P/B i: 1.15
Debt / Equity i: 0.17
Operating Margin: -566038.89%
Net Margin: -762355.56%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.17
Current Ratio: 5.28
Quick Ratio: 5.28
Status: Good

Insider Transactions

Recent executive and insider activity

Innovative Cellular Therapeutics Holdings Ltd
Transaction: 06/29/2026
SELL
Change
-76,000
Price
Not reported
Filing
07/01/2026
Type
SELL
Innovative Cellular Therapeutics Holdings Ltd
Transaction: 06/15/2026
SELL
Change
-66,500
Price
Not reported
Filing
06/18/2026
Type
SELL
Innovative Cellular Therapeutics Holdings Ltd
Transaction: 05/18/2026
OTHER
Change
0
Price
Not reported
Filing
06/18/2026
Type
OTHER